Clinical Trial Update: A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the safety and tolerability of oral ziprasidone in children and adolescents with psychotic disorders completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Ziprasidone (ziprasidone)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Schizophrenia, Bipolar Disorder | Phase 2 | Status: COMPLETED